211 related articles for article (PubMed ID: 33005611)
1. Muir-Torre Syndrome Associated Periocular Sebaceous Neoplasms: Screening Patterns in the Literature and in Clinical Practice.
Eiger-Moscovich M; Eagle RC; Shields CL; Racher H; Lally SE; Silkiss RZ; Shields JA; Milman T
Ocul Oncol Pathol; 2020 Aug; 6(4):226-237. PubMed ID: 33005611
[TBL] [Abstract][Full Text] [Related]
2. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
Rishi K; Font RL
Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
[TBL] [Abstract][Full Text] [Related]
3. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome.
Gaskin BJ; Fernando BS; Sullivan CA; Whitehead K; Sullivan TJ
Br J Ophthalmol; 2011 Dec; 95(12):1686-90. PubMed ID: 21979897
[TBL] [Abstract][Full Text] [Related]
4. Metachronous occurrence of colorectal cancer in a muir-torre syndrome patient presenting with recurrent sebaceous adenoma of the eyelid: case report and updated review of the literature.
Agiannidis C; Pana ZD; Molyva D; Kalokasidis K; Mixiou M
J Cutan Med Surg; 2012; 16(6):394-9. PubMed ID: 23149194
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry, Molecular Biology, and Clinical Scoring for the Detection of Muir-Torre Syndrome in Cutaneous Sebaceous Tumors: Which Strategy?
Sinson H; Karayan-Tapon L; Godet J; Rivet P; Alleyrat C; Battistella M; Pierron H; Morel F; Lecron JC; Favot L; Frouin E
Dermatology; 2023; 239(6):889-897. PubMed ID: 37717564
[TBL] [Abstract][Full Text] [Related]
6. Muir-Torre syndrome appropriate use criteria: Effect of patient age on appropriate use scores.
; Vidal CI; Sutton A; Armbrect EA; Lee JB; Litzner BR; Hurley MY; ; Alam M; Duncan LM; Elston DM; Emanuel PO; Ferringer T; Fung MA; Hosler GA; Lazar AJ; Lowe L; Plaza JA; Robinson JK; Schaffer A
J Cutan Pathol; 2019 Jul; 46(7):484-489. PubMed ID: 30895633
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
[TBL] [Abstract][Full Text] [Related]
8. Muir-Torre syndrome: a rare but important disorder.
Hare HH; Mahendraker N; Sarwate S; Tangella K
Cutis; 2008 Oct; 82(4):252-6. PubMed ID: 19055168
[TBL] [Abstract][Full Text] [Related]
9. Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018.
Cook S; Pethick J; Kibbi N; Hollestein L; Lavelle K; de Vere Hunt I; Turnbull C; Rous B; Husain A; Burn J; Lüchtenborg M; Santaniello F; McRonald F; Hardy S; Linos E; Venables Z; Rajan N
J Am Acad Dermatol; 2023 Dec; 89(6):1129-1135. PubMed ID: 37031776
[TBL] [Abstract][Full Text] [Related]
10. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome.
Simic D; Dummer R; Freiberger SN; Ramelyte E; Barysch MJ
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065301
[TBL] [Abstract][Full Text] [Related]
12. Muir-Torre syndrome.
Lachiewicz AM; Wilkinson TM; Groben P; Ollila DW; Thomas NE
Am J Clin Dermatol; 2007; 8(5):315-9. PubMed ID: 17902735
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
Abbas O; Mahalingam M
J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
[TBL] [Abstract][Full Text] [Related]
14. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management.
John AM; Schwartz RA
J Am Acad Dermatol; 2016 Mar; 74(3):558-66. PubMed ID: 26892655
[TBL] [Abstract][Full Text] [Related]
15. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
[TBL] [Abstract][Full Text] [Related]
16. Extraocular well-differentiated sebaceous tumors with overlying cutaneous horns: four tumors in three patients.
Jhuang JY; Liao SL; Tsai JH; Chang HC; Kuo KT; Liau JY
J Cutan Pathol; 2014 Aug; 41(8):650-6. PubMed ID: 24548110
[TBL] [Abstract][Full Text] [Related]
17. Muir-Torre syndrome.
Bhaijee F; Brown AS
Arch Pathol Lab Med; 2014 Dec; 138(12):1685-9. PubMed ID: 25427047
[TBL] [Abstract][Full Text] [Related]
18. Metastatic Prostatic Adenocarcinoma in Patient With Muir-Torre Syndrome Misdiagnosed as Metastatic Sebaceous Carcinoma: Case Report and Systematic Literature Review.
Cattelan L; Abi-Rafeh J; Brimo F; Kazan R; Redpath M; Chergui M
Am J Dermatopathol; 2020 Sep; 42(9):700-705. PubMed ID: 32568842
[TBL] [Abstract][Full Text] [Related]
19. Muir-Torre syndrome: a case report and review of the literature.
Pettey AA; Walsh JS
Cutis; 2005 Mar; 75(3):149-55. PubMed ID: 15839358
[TBL] [Abstract][Full Text] [Related]
20. Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome.
Font RL; Rishi K
Ophthalmology; 2003 Sep; 110(9):1833-6. PubMed ID: 13129885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
